Compare ADSK & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADSK | BDX |
|---|---|---|
| Founded | 1982 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.8B | 43.0B |
| IPO Year | 1994 | 1997 |
| Metric | ADSK | BDX |
|---|---|---|
| Price | $209.75 | $156.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 13 |
| Target Price | ★ $335.04 | $186.00 |
| AVG Volume (30 Days) | ★ 2.0M | 1.9M |
| Earning Date | 05-21-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.89% |
| EPS Growth | ★ 2.15 | N/A |
| EPS | ★ 2.32 | 0.25 |
| Revenue | $7,206,000,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $15.35 | N/A |
| Revenue Next Year | $10.36 | $3.02 |
| P/E Ratio | ★ $88.47 | $611.88 |
| Revenue Growth | ★ 17.53 | 8.24 |
| 52 Week Low | $185.50 | $140.11 |
| 52 Week High | $329.09 | $213.08 |
| Indicator | ADSK | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | 55.88 |
| Support Level | $198.01 | $153.27 |
| Resistance Level | $218.90 | $160.40 |
| Average True Range (ATR) | 7.23 | 3.78 |
| MACD | 0.73 | -0.12 |
| Stochastic Oscillator | 49.41 | 54.76 |
Founded in 1982, Autodesk is a multinational software company best known for pioneering computer-aided design, or CAD, with its AutoCAD product. Nowadays, Autodesk provides design software for a variety of verticals, including architecture & construction, manufacturing, and media & entertainment. Autodesk products have been used in some of the world's most iconic landmarks, like Burj Khalifa, and well-known movie titles like Avatar.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.